The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Shaner, A.
* Articles by Hsieh, S. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Shaner, A.
* Articles by Hsieh, S. C.

Am J Psychiatry 1993; 150:758-762
Copyright © 1993 by American Psychiatric Association


REGULAR ARTICLES

Unrecognized cocaine use among schizophrenic patients

A Shaner, ME Khalsa, L Roberts, J Wilkins, D Anglin and SC Hsieh
West Los Angeles VA Medical Center, CA 90073.

OBJECTIVE: Unrecognized stimulant use could lead to the misdiagnosis of schizophrenia or the misunderstanding of its course and prognosis. This study was conducted to determine the prevalence of unrecognized stimulant use among patients with a clinical diagnosis of schizophrenia. METHOD: The subjects were 108 schizophrenic patients admitted consecutively to a Veterans Affairs psychiatric hospital. Admitting psychiatrists supplemented routine clinical evaluations with a semistructured interview regarding recent and lifetime use of alcohol, cocaine, amphetamine, marijuana, and opiates. A urine specimen was assayed for the four illicit drugs. RESULTS: Of the 103 patients who provided a urine specimen, 37 (36%) used cocaine during the 6 months before admission, including 31 who used the drug in the week before admission. Because of the poor reliability of negative self- reports of recent cocaine use, clinicians failed to recognize cocaine use in one-third of the patients with a urine toxicology positive for cocaine metabolites. Two other groups of patients were identified; schizophrenic patients without substance abuse (including alcohol) and schizophrenic patients with substance abuse other than stimulants. Both substance-abusing groups were younger than the nonabusing group, but the three groups had similarly high rates of recent psychotic symptoms, homelessness, and unemployment. CONCLUSIONS: Among schizophrenic patients who require hospitalization, clinicians should not rely solely on self-reported stimulant use. Recognition of stimulant use could be improved through routine urine toxicologies for all psychotic patients. The authors suggest that recognition of stimulant use among schizophrenic patients may identify a population with a better prognosis for schizophrenia and different treatment needs.


This article has been cited by other articles:


Home page
Criminal Justice and BehaviorHome page
W. M. Dinn, D. A. Gansler, N. Moczynski, and C. Fulwiler
Brain Dysfunction and Community Violence in Patients With Major Mental Illness
Criminal Justice and Behavior, February 1, 2009; 36(2): 117 - 136.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
G. Wolford, S. D. Rosenberg, H. J. Rosenberg, M. S. Swartz, M. I. Butterfield, J. W. Swanson, and M. K. Jankowski
A Clinical Trial Comparing Interviewer and Computer-Assisted Assessment Among Clients With Severe Mental Illness
Psychiatr Serv, July 1, 2008; 59(7): 769 - 775.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
K. T. Brady and R. Sinha
Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress
Focus, January 1, 2007; 5(2): 229 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
S. Venneman, A. Leuchter, G. Bartzokis, M. Beckson, S. L. Simon, M. Schaefer, R. Rawson, T. Newton, I. A. Cook, S. Uijtdehaage, et al.
Variation in Neurophysiological Function and Evidence of Quantitative Electroencephalogram Discordance: Predicting Cocaine-Dependent Treatment Attrition
J Neuropsychiatry Clin Neurosci, May 1, 2006; 18(2): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
B. GREEN, R. YOUNG, and D. KAVANAGH
Cannabis use and misuse prevalence among people with psychosis
The British Journal of Psychiatry, October 1, 2005; 187(4): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
K. T. Brady and R. Sinha
Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress
Am J Psychiatry, August 1, 2005; 162(8): 1483 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Bull.Home page
A. Ley, D. Jeffery, J. Ruiz, S. McLaren, and C. Gillespie
Underdetection of comorbid drug use at acute psychiatric admission
Psychiatr. Bull., July 1, 2002; 26(7): 248 - 251.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
P. J. DUKE, C. PANTELIS, M. A. McPHILLIPS, and T. R. E. BARNES
Comorbid non-alcohol substance misuse among people with schizophrenia: Epidemiological study in central London
The British Journal of Psychiatry, December 1, 2001; 179(6): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. RachBeisel, J. Scott, and L. Dixon
Co-Occurring Severe Mental Illness and Substance Use Disorders: A Review of Recent Research
Psychiatr Serv, November 1, 1999; 50(11): 1427 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. P. Ho, J. W. Tsuang, R. P. Liberman, R. Wang, J. N. Wilkins, T. A. Eckman, and A. L. Shaner
Achieving Effective Treatment of Patients With Chronic Psychotic Illness and Comorbid Substance Dependence
Am J Psychiatry, November 1, 1999; 156(11): 1765 - 1770.
[Abstract] [Full Text]


Home page
J Am Psychiatr Nurses AssocHome page
K. H. Littrell and S. H. Littrell
Schizophrenia and Comorbid Substance Abuse
Journal of the American Psychiatric Nurses Association, April 1, 1999; 5(2): S17 - S24.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
A. Shaner, L. J. Roberts, T. A. Eckman, J. M. Racenstein, D. E. Tucker, J. W. Tsuang, and J. Mintz
Sources of Diagnostic Uncertainty for Chronically Psychotic Cocaine Abusers
Psychiatr Serv, May 1, 1998; 49(5): 684 - 690.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
S. D. Rosenberg, R. E. Drake, G. L. Wolford, K. T. Mueser, T. E. Oxman, R. M. Vidaver, K. L. Carrieri, and R. Luckoor
Dartmouth Assessment of Lifestyle Instrument (DALI): A Substance Use Disorder Screen for People With Severe Mental Illness
Am J Psychiatry, February 1, 1998; 155(2): 232 - 238.
[Abstract] [Full Text]


Home page
J Am Psychiatr Nurses AssocHome page
K. H. Littrell and S. H. Littrell
Treatment-refractory Schizophrenia: Update on Concepts and Interventions
Journal of the American Psychiatric Nurses Association, February 1, 1998; 4(1): S18 - S28.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
J. E. Kirchner, R. R. Owen, C. Nordquist, and E. P. Fischer
Diagnosis and Management of Substance Use Disorders Among Inpatients With Schizophrenia
Psychiatr Serv, January 1, 1998; 49(1): 82 - 85.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
R. D. Weiss, L. M. Najavits, S. F. Greenfield, J. A. Soto, S. R. Shaw, and D. Wyner
Validity of Substance Use Self-Reports in Dually Diagnosed Outpatients
Am J Psychiatry, January 1, 1998; 155(1): 127 - 128.
[Abstract] [Full Text]


Home page
NEJMHome page
A. Shaner, T. A. Eckman, L. J. Roberts, J. N. Wilkins, D. E. Tucker, J. W. Tsuang, and J. Mintz
Disability Income, Cocaine Use, and Repeated Hospitalization among Schizophrenic Cocaine Abusers -- A Government-Sponsored Revolving Door?
N. Engl. J. Med., September 21, 1995; 333(12): 777 - 783.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1993 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org